
CAS Name: N-[2-(Diethylamino)ethyl]-4-[(methylsulfonyl)amino]benzamidePercent Composition: C 53.65%, H 7.40%, N 13.41%, O 15.31%, S 10.23%
Literature References: Prepn: D. D. Davey et al., US 4544654 (1985 to Schering AG); W. C. Lumma, Jr. et al., J. Med. Chem. 30, 755 (1987). Pharmacology: S. S. Greenberg et al., Drug Dev. Res. 25, 283 (1992). Pharmacokinetics and HPLC determn in plasma: S. Dancik et al., J. Pharm. Sci. 80, 157 (1991). Clinical pharmacology: W. Wong et al., Am. J. Cardiol. 69, 206 (1992). Electrophysiologic profile: P. T. Sager et al., Circulation 88, 1072 (1993). Review: T. A. Argentieri, Cardiovasc. Drug Rev. 10, 182-198 (1992).
CAS Name: 2-(4-Chlorophenyl)-a-methyl-5-benzoxazoleacetic acidTrademarks: Coxigon (Lilly); Opren (Lilly); Oraflex (Lilly)
Percent Composition: C 63.69%, H 4.01%, Cl 11.75%, N 4.64%, O 15.91%
Literature References: Prepn: D. Evans et al., DE 2324443; eidem, US 3912748 (1973, 1975 both to Lilly); D. W. Dunwell et al., J. Med. Chem. 18, 53 (1975). Analysis by HPLC: S. W. McKay et al., J. Chromatogr. 170, 482 (1979). Pharmacokinetics: D. H. Chatfield et al., Br. J. Clin. Pharmacol. 4, 579 (1977). Metabolism: D. H. Chatfield, J. N. Green, Xenobiotica 8, 133 (1978). Effect on lysosomal enzyme secretion: R. J. Smith, J. Pharmacol. Exp. Ther. 207, 618 (1978). Dissolution and absorption in humans: A. S. Ridolfo et al., J. Pharm. Sci. 68, 850 (1979). Series of clinical studies: Rheumatol. Rehabil. 17, 254-264 (1978). Retrospective study of molecular toxicology: D. F. V. Lewis et al., Toxicology 65, 33 (1990).
CAS Name: N,2,3-Trimethyl-2-(1-methylethyl)butanamide
Additional Names: 2-isopropyl-N,2,3-dimethylbutanamidePercent Composition: C 70.12%, H 12.36%, N 8.18%, O 9.34%
Literature References: Prepn: D. G. Rowsell et al., DE 2317538; eidem, US 4296255 (1973, 1981 both to Wilkinson Sword). Structure-activity study: H. R. Watson et al., J. Soc. Cosmet. Chem. 29, 185 (1978). Brief review: M. A. Parrish, Manuf. Chem. 58, 31-32 (February, 1987).
CAS Name: 1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1H-benzimidazole
Additional Names: 1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)benzimidazole; 1-(p-chlorobenzyl)-2-pyrrolidylmethyle...
Literature References: Prepn: D. Jerchel et al., Ann. 575, 162 (1952); GB 703272; M. Schenck, W. Heinz, US 2689853 (both 1954 to Schering A.G.).
CAS Name: 2-Propyl-4-pyridinecarbothioamide
Additional Names: 2-propylthioisonicotinamide; prothionamide; 2-propyl-4-thiocarbamoylpyridine
Trademarks: Ektebin (Hefa); Peteha (Fatol); Trevint...
Literature References: Prepn: D. Liberman et al., Compt. Rend. 242, 2409 (1956); GB 800250, D. Liberman, US 2901488 (1958, 1959 both to Chimie et Atomistique); L. N. Yakhontov et al., Khim. Farm. Zh. 10, 96 (1976), C.A. 85, 32787h (1976). Pharmacology: A. M. Il'in, Farmakol. Toksikol. 38, 471 (1975).
CAS Name: N,N'-(1,10-Decanediyldi-1(4H)-pyridinyl-4-ylidene)bis[1-octanamine]
Additional Names: 1,10-bis-[4-(octylamino)-1-pyridinium]decanePercent Composition: C 78.49%, H 11.34%, N 10.17%
Literature References: Prepn: D. M. Bailey, BE 851807; idem, US 4206215 (1977, 1980 both to Sterling); D. M. Bailey et al., J. Med. Chem. 27, 1457 (1984). Structure-activity study: A. M. Slee et al., Antimicrob. Agents Chemother. 23, 531 (1983). Antiplaque activity: A. M. Slee, J. R. O'Connor, ibid. 379; microbiocidal activity: D. M. Sedlock, D. M. Bailey, ibid. 28, 786 (1985). Antimycotic effects: M. A. Ghannoum et al., J. Antimicrob. Chemother. 25, 237 (1990). Clinical evaluation as topical disinfectant: B. Christiansen, Z. Bakteriol. Mikrobiol. Hyg. 186, 368 (1988). Clinical trials in prevention of plaque and gingivitis: M. R. Patters et al., J. Periodontal Res. 21, 154 (1986); B. B. Beiswanger et al., J. Dent. Res. 69, 454 (1990).
CAS Name: 2-Furancarboxylic acid 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinyl ester
Additional Names: 2-furoic acid ester with 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol; 1-(dichl...
Literature References: Prepn: D. M. Bailey, US 3997542 (1976 to Sterling); D. M. Bailey et al., J. Med. Chem. 22, 600 (1979). Amebicidal activity and toxicological evaluation: R. G. Slighter et al., Parasitology 81, 157 (1980). Distribution and metabolism in rats: J. F. Baker, Arch. Int. Pharmacodyn. 258, 29 (1982). HPLC determn in biological samples: J. M. Morales et al., J. Chromatogr. B 746, 133 (2000). Clinical evaluation in adults with chronic amebiasis: L. Guevara et al., Clin. Ther. 6, 43 (1983); in children: F. A. Rojas et al., ibid. 47.
CAS Name: 3-(3,5-Dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione
Additional Names: 3-(3,5-dichlorophenyl)-5-methyl-5-vinyloxazolidine-2,4-dioneTrademarks: Ronilan (BASF); Vorlan (Mallin...
Literature References: Prepn: D. Mangold et al., DE 2207576 (1973 to BASF), C.A. 79, 137120q (1973). Activity: C. Hess, F. Locher, Proc. Brit. Insectic. Fungic. Conf. 2, 693 (1975). Comparative mechanism of action: A. C. Pappas, D. J. Fisher, Pestic. Sci. 10, 239 (1979).
CAS Name: 2-(4-Morpholinylmethyl)-2-phenyl-1H-indene-1,3(2H)-dione
Additional Names: 2-phenyl-2-morpholinomethylindane-1,3-dione; mofedioneTrademarks: Transidione (Dausse); Amplidione (Dausse)<...
Literature References: Prepn: D. P. R. Giudicelli, H. Najer, ZA 69 02814 (1969 to Lab. Dausse), C.A. 72, 111159q (1970).
CAS Name: Diethylpropanedioic acid
Additional Names: 3,3-pentanedicarboxylic acid
Percent Composition: C 52.49%, H 7.55%, O 39.96%
Literature References: Prepn: Daimler, Ann. 249, 173 (1888); Speck, J. Am. Chem. Soc. 74, 2876 (1952). Spectral studies: J. L. Delarbre et al., J. Raman Spectrosc. 16, 11 (1985). Crystal structure: A. Dubourg et al., Acta Crystallogr. C44, 1987 (1988).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
